FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604708549> ?p ?o ?g. }

• W2604708549 endingPage "1267" @default.
• W2604708549 startingPage "1260" @default.
• W2604708549 abstract "Despite the availability of effective antiemetics and evidence-based guidelines, up to 40% of cancer patients receiving chemotherapy fail to achieve complete nausea and vomiting control. In addition to type of chemotherapy, several patient-related risk factors for chemotherapy-induced nausea and vomiting (CINV) have been identified. To incorporate these factors into the optimal selection of prophylactic antiemetics, a repeated measures cycle-based model to predict the risk of ≥ grade 2 CINV (≥2 vomiting episodes or a decrease in oral intake due to nausea) from days 0 to 5 post-chemotherapy was developed.Data from 1198 patients enrolled in one of the five non-interventional CINV prospective studies were pooled. Generalized estimating equations were used in a backwards elimination process with the P-value set at <0.05 to identify the relevant predictive factors. A risk scoring algorithm (range 0-32) was then derived from the final model coefficients. Finally, a receiver-operating characteristic curve (ROCC) analysis was done to measure the predictive accuracy of the scoring algorithm.Over 4197 chemotherapy cycles, 42.2% of patients experienced ≥grade 2 CINV. Eight risk factors were identified: patient age <60 years, the first two cycles of chemotherapy, anticipatory nausea and vomiting, history of morning sickness, hours of sleep the night before chemotherapy, CINV in the prior cycle, patient self-medication with non-prescribed treatments, and the use of platinum or anthracycline-based regimens. The ROC analysis indicated good predictive accuracy with an area-under-the-curve of 0.69 (95% CI: 0.67-0.70). Before to each cycle of therapy, patients with risk scores ≥16 units would be considered at high risk for developing ≥grade 2 CINV.The clinical application of this prediction tool will be an important source of individual patient risk information for the oncology clinician and may enhance patient care by optimizing the use of the antiemetics in a proactive manner." @default.
• W2604708549 created "2017-04-14" @default.
• W2604708549 creator A5004621461 @default.
• W2604708549 creator A5018823440 @default.
• W2604708549 creator A5026483927 @default.
• W2604708549 creator A5033285318 @default.
• W2604708549 creator A5059391185 @default.
• W2604708549 creator A5072563567 @default.
• W2604708549 creator A5078386925 @default.
• W2604708549 creator A5083880304 @default.
• W2604708549 creator A5089808394 @default.
• W2604708549 date "2017-06-01" @default.
• W2604708549 modified "2023-10-17" @default.
• W2604708549 title "The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting" @default.
• W2604708549 cites W1965206573 @default.
• W2604708549 cites W1970880506 @default.
• W2604708549 cites W1974362328 @default.
• W2604708549 cites W2010263277 @default.
• W2604708549 cites W2019300001 @default.
• W2604708549 cites W2037750236 @default.
• W2604708549 cites W2045564257 @default.
• W2604708549 cites W2047765875 @default.
• W2604708549 cites W2052832896 @default.
• W2604708549 cites W2061936275 @default.
• W2604708549 cites W2074932800 @default.
• W2604708549 cites W2082376914 @default.
• W2604708549 cites W2083463299 @default.
• W2604708549 cites W2083688974 @default.
• W2604708549 cites W2133300915 @default.
• W2604708549 cites W2142195688 @default.
• W2604708549 cites W2155440673 @default.
• W2604708549 cites W2157825442 @default.
• W2604708549 cites W2161090649 @default.
• W2604708549 cites W2178110272 @default.
• W2604708549 cites W2285443608 @default.
• W2604708549 cites W2320891340 @default.
• W2604708549 cites W2460792208 @default.
• W2604708549 cites W2471819257 @default.
• W2604708549 cites W2527377692 @default.
• W2604708549 cites W932835970 @default.
• W2604708549 doi "https://doi.org/10.1093/annonc/mdx100" @default.
• W2604708549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5452068" @default.
• W2604708549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28398530" @default.
• W2604708549 hasPublicationYear "2017" @default.
• W2604708549 type Work @default.
• W2604708549 sameAs 2604708549 @default.
• W2604708549 citedByCount "117" @default.
• W2604708549 countsByYear W26047085492017 @default.
• W2604708549 countsByYear W26047085492018 @default.
• W2604708549 countsByYear W26047085492019 @default.
• W2604708549 countsByYear W26047085492020 @default.
• W2604708549 countsByYear W26047085492021 @default.
• W2604708549 countsByYear W26047085492022 @default.
• W2604708549 countsByYear W26047085492023 @default.
• W2604708549 crossrefType "journal-article" @default.
• W2604708549 hasAuthorship W2604708549A5004621461 @default.
• W2604708549 hasAuthorship W2604708549A5018823440 @default.
• W2604708549 hasAuthorship W2604708549A5026483927 @default.
• W2604708549 hasAuthorship W2604708549A5033285318 @default.
• W2604708549 hasAuthorship W2604708549A5059391185 @default.
• W2604708549 hasAuthorship W2604708549A5072563567 @default.
• W2604708549 hasAuthorship W2604708549A5078386925 @default.
• W2604708549 hasAuthorship W2604708549A5083880304 @default.
• W2604708549 hasAuthorship W2604708549A5089808394 @default.
• W2604708549 hasBestOaLocation W26047085491 @default.
• W2604708549 hasConcept C121608353 @default.
• W2604708549 hasConcept C126322002 @default.
• W2604708549 hasConcept C143998085 @default.
• W2604708549 hasConcept C2776694085 @default.
• W2604708549 hasConcept C2776802502 @default.
• W2604708549 hasConcept C2779924295 @default.
• W2604708549 hasConcept C2780580376 @default.
• W2604708549 hasConcept C2780852908 @default.
• W2604708549 hasConcept C2780884295 @default.
• W2604708549 hasConcept C42219234 @default.
• W2604708549 hasConcept C530470458 @default.
• W2604708549 hasConcept C58471807 @default.
• W2604708549 hasConcept C71924100 @default.
• W2604708549 hasConceptScore W2604708549C121608353 @default.
• W2604708549 hasConceptScore W2604708549C126322002 @default.
• W2604708549 hasConceptScore W2604708549C143998085 @default.
• W2604708549 hasConceptScore W2604708549C2776694085 @default.
• W2604708549 hasConceptScore W2604708549C2776802502 @default.
• W2604708549 hasConceptScore W2604708549C2779924295 @default.
• W2604708549 hasConceptScore W2604708549C2780580376 @default.
• W2604708549 hasConceptScore W2604708549C2780852908 @default.
• W2604708549 hasConceptScore W2604708549C2780884295 @default.
• W2604708549 hasConceptScore W2604708549C42219234 @default.
• W2604708549 hasConceptScore W2604708549C530470458 @default.
• W2604708549 hasConceptScore W2604708549C58471807 @default.
• W2604708549 hasConceptScore W2604708549C71924100 @default.
• W2604708549 hasIssue "6" @default.
• W2604708549 hasLocation W26047085491 @default.
• W2604708549 hasLocation W26047085492 @default.
• W2604708549 hasLocation W26047085493 @default.
• W2604708549 hasLocation W26047085494 @default.
• W2604708549 hasOpenAccess W2604708549 @default.
• W2604708549 hasPrimaryLocation W26047085491 @default.

• next